Paresthesia-Free Fast-Acting Subperception (FAST) Study

NCT ID: NCT04618471

Last Updated: 2025-12-23

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

177 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-10

Study Completion Date

2029-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study to evaluate the effectiveness of FAST-SCS (fast-acting paresthesia-free therapy) and additional SCS therapy options in patients with chronic pain using Boston Scientific WaveWriter SCS Systems.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Spinal Cord Stimulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

WaveWriter Settings

Group Type EXPERIMENTAL

Boston Scientific WaveWriter SCS System

Intervention Type DEVICE

WaveWriter SCS Programming

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Boston Scientific WaveWriter SCS System

WaveWriter SCS Programming

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronic pain (predominantly neuropathic) of the trunk and/or limbs for at least 6 months with back pain greater or equal to leg pain.
* 22 years of age or older when written informed consent is obtained
* Able to independently read and complete all questionnaires and assessments provided in English
* Signed a valid, IRB-approved informed consent form (ICF) provided in English

Exclusion Criteria

* Any pain-related diagnosis or medical/psychological condition or external factors that, in the clinician's best judgment, might confound reporting of study outcomes
* Significant cognitive impairment that, in the opinion of the Investigator, would reasonably be expected to impair the study candidate's ability to participate in the study
* Breast-feeding or planning to get pregnant during the course of the study or not using adequate contraception
* Participating, or intends to participate, in another clinical trial that may influence the data that will be collected for this study
Minimum Eligible Age

22 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Scientific Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Natalie Bloom Lyons

Role: STUDY_DIRECTOR

Boston Scientific Corporation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vitamed Research

Palm Desert, California, United States

Site Status

Denver Back Pain Specialists

Greenwood Village, Colorado, United States

Site Status

Orlando Health Neuroscience Institute

Clermont, Florida, United States

Site Status

The Orthopaedic Institute

Gainesville, Florida, United States

Site Status

University of Chicago Hospital

Chicago, Illinois, United States

Site Status

Goodman Campbell Brain and Spine

Carmel, Indiana, United States

Site Status

Willis-Knighton River Cities Clinical Research Center

Shreveport, Louisiana, United States

Site Status

Montefiore Medical Center

The Bronx, New York, United States

Site Status

The Center for Clinical Research

Winston-Salem, North Carolina, United States

Site Status

Cleveland Clinic Foundation

Cleveland, Ohio, United States

Site Status

Pacific Sports and Spine, LLC

Eugene, Oregon, United States

Site Status

PCPMG Clinical Research Unit, LLC

Greenville, South Carolina, United States

Site Status

Acute and Chronic Pain Therapies

Bellevue, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A4099

Identifier Type: -

Identifier Source: org_study_id